Table 2.
Mean and standard deviation of the number of valid trials and proportion of first-look target hits for each outcome group.
| HR-ASD | HR-ATYP | HR-TD | Low Risk | |
|---|---|---|---|---|
| Visit 1–9 months | ||||
| Valid trials (SD) N Target hits (SD) N |
16.24 (2.63) 17 .26 (.16) 17 |
13.58 (4.05) 31 .17 (.12) 29 |
12.91 (4.57) 64 .17 (.11) 58 |
12.22 (4.98) 27 .14 (.09) 27 |
| Visit 2–15 months | ||||
| Valid trials (SD) N Target hits (SD) N |
13.00 (6.64) 14 .28 (.12) 11 |
13.97 (6.10) 29 .16 (.13) 26 |
13.00 (5.21) 64 .19 (.14) 57 |
12.31 (5.18) 26 .11 (.10) 25 |
| Visit 3–2 years | ||||
| Valid trials (SD) N Target hits (SD) N |
10.88 (3.18) 17 .31 (.18) 15 |
10.74 (3.58) 27 .28 (.15) 20 |
9.71 (4.04) 58 .29 (.19) 44 |
9.76 (3.17) 26 .26 (.18) 24 |